{
    "id": "0027",
    "question": "A 26-year-old woman presents to a gynecologist after a missed period. After performing a complete physical examination and a screening test for pregnancy, her gynecologist informs her that she is pregnant. She is very surprised as she has been taking oral contraceptives regularly. When the gynecologist asks her about the consumption of any other medications, she mentions that she was placed on treatment for pulmonary tuberculosis (TB) 2 months ago. Her current anti-TB regimen includes rifampin, isoniazid, pyrazinamide, and ethambutol. Which of the following mechanisms best explains the failure of oral contraceptives in this patient?",
    "options": {
        "A": "Induction of CYP3A4 by rifampin leading to decreased serum levels of ethinylestradiol and progesterone",
        "B": "Induction of CYP2A6 by rifampin leading to increased inactivation of ethinylestradiol",
        "C": "Interference with the intestinal absorption of the oral contraceptive by pyrazinamide",
        "D": "Increased renal elimination of the progesterone component of the oral contraceptive by ethambutol"
    },
    "answer": "A",
    "predict": "{\"step_by_step_thinking\": \"The patient is taking oral contraceptives and has been diagnosed with pulmonary tuberculosis (TB) and is on a regimen of rifampin, isoniazid, pyrazinamide, and ethambutol. To determine why the oral contraceptives are not working, we need to consider the potential interactions between the TB medications and the oral contraceptives. Rifampin is a well-known inducer of the CYP3A4 enzyme, which is responsible for metabolizing ethinylestradiol and progesterone, the active components of oral contraceptives. Induction of CYP3A4 by rifampin can lead to decreased serum levels of these hormones, making the oral contraceptives less effective. The other options are less likely to be the cause of the failure of oral contraceptives in this patient. Pyrazinamide is not typically associated with significant interactions with oral contraceptives, and ethambutol is not known to affect the renal elimination of progesterone. Therefore, the most likely explanation for the failure of oral contraceptives in this patient is the induction of CYP3A4 by rifampin, leading to decreased serum levels of ethinylestradiol and progesterone.\", \"answer_choice\": \"A\"}}",
    "snippets": [
        {
            "id": "Pharmacology_Katzung_3731",
            "title": "Pharmacology_Katzung",
            "content": "James L. Zehnder, MD and edema and is tender to touch. Oxygen saturation by fingertip pulse oximeter while breathing room air is 87% (normal > 90%). Ultrasound reveals a deep vein thrombosis in the left lower extremity; chest computed tomography scan confirms the presence of pulmonary emboli. Laboratory blood tests indicate elevated d-dimer levels. What therapy is indicated acutely? What are the long-term therapy options? How long should she be treated? Should this indi-vidual use oral contraceptives? A 25-year-old woman presents to the emergency depart-ment complaining of acute onset of shortness of breath and pleuritic pain. She had been in her usual state of health until 2 days prior when she noted that her left leg was swollen and red. Her only medication was oral contraceptives. Family history was significant for a history of \u201cblood clots\u201d in mul-tiple members of the maternal side of her family. Physical examination demonstrates an anxious woman with stable vital signs. The left"
        },
        {
            "id": "Gynecology_Novak_753",
            "title": "Gynecology_Novak",
            "content": "Thyroid-stimulating hormone Strong family history of thyroid disease; autoimmune disease (evidence of subclinical testing hypothyroidism may be related to unfavorable lipid profiles) Tuberculosis skin testing HIV infection; close contact with individuals known or suspected to have tuberculosis; medical risk factors known to increase risk of disease if infected; born in country with high tuberculosis prevalence; medically underserved; low income; alcoholism; intravenous drug use; resident of long-term care facility (eg, correctional institutions, mental institutions, nursing homes and facilities); health professional working in high-risk health care facilities; recent tuberculin skin test converter (individuals with baseline testing results who have an increase of 10 mm or more in the size of the tuberculin skin test reaction within a 2-year period); radiographic evidence of prior healed tuberculosis"
        },
        {
            "id": "Pharmacology_Katzung_5050",
            "title": "Pharmacology_Katzung",
            "content": "Camille E. Beauduy, PharmD, & Lisa G. Winston, MD motion tenderness is present. A first-catch urine specimen is obtained for chlamydia and gonorrhea nucleic acid amplifi-cation testing. A urine pregnancy test is also ordered as the patient reports she \u201cmissed her last period.\u201d Pending these results, the decision is made to treat her presumptively for chlamydial cervicitis. What are two potential treatment options for her possible chlamydial infection? How does her potential pregnancy affect the treatment decision? A 22-year-old woman presents to her college medical clinic complaining of a 2-week history of vaginal discharge. She denies any fever or abdominal pain but does report vaginal bleeding after sexual intercourse. When questioned about her sexual activity, she reports having vaginal intercourse, at times unprotected, with two men in the last 6 months. A pelvic examination is performed and is positive for muco-purulent discharge from the endocervical canal. No cervical"
        },
        {
            "id": "Pharmacology_Katzung_4444",
            "title": "Pharmacology_Katzung",
            "content": "The Gonadal Hormones & Inhibitors George P. Chrousos, MD A 25-year-old woman with menarche at 13 years and menstrual periods until about 1 year ago complains of hot flushes, skin and vaginal dryness, weakness, poor sleep, and scanty and infrequent menstrual periods of a year\u2019s dura-tion. She visits her gynecologist, who obtains plasma levels of follicle-stimulating hormone and luteinizing hormone, both of which are moderately elevated. She is diagnosed with premature ovarian failure, and estrogen and pro-gesterone replacement therapy is recommended. A dual-energy absorptiometry scan (DEXA) reveals a bone density t-score of <2.5 SD, ie, frank osteoporosis. How should the ovarian hormones she lacks be replaced? What extra mea-sures should she take for her osteoporosis while receiving treatment? \u25a0 THE OVARY (ESTROGENS, PROGESTINS, OTHER OVARIAN HORMONES, ORAL CONTRACEPTIVES, INHIBITORS & ANTAGONISTS, & OVULATIONINDUCING AGENTS)"
        },
        {
            "id": "Pharmacology_Katzung_3234",
            "title": "Pharmacology_Katzung",
            "content": "What CYP450 and pharmacodynamic interactions might be associated with fluoxetine use in this patient? Which class of antidepressants would be contraindicated in this patient? A 47-year-old woman presents to her primary care physician with a chief complaint of fatigue. She indicates that she was promoted to senior manager in her company approximately 11 months earlier. Although her promotion was welcome and came with a sizable raise in pay, it resulted in her having to move away from an office and group of colleagues she very much enjoyed. In addition, her level of responsibility increased dramatically. The patient reports that for the last 7 weeks, she has been waking up at 3 am every night and been unable to go back to sleep. She dreads the day and the stresses of the workplace. As a consequence, she is not eating as well as she might and has dropped 7% of her body weight in the last 3 months. She also reports being so stressed that she breaks down crying in the office occasionally"
        },
        {
            "id": "Gynecology_Novak_1978",
            "title": "Gynecology_Novak",
            "content": "A patient who is mildly anemic will benefit from hormone therapy. If the patient is not bleeding at the time of evaluation and has no contraindications to the use of estrogen, a combination low-dose oral contraceptive can be prescribed for use in the manner in which it is used for contraception. If the patient is not sexually active, she should be reevaluated after three to six cycles to determine whether she desires to continue this regimen. Parents may sometimes object to the use of oral contraceptives if their daughter is not sexually active (or if they believe her not to be or even if they would like her not to be). These objections are frequently based on misconceptions about the potential risks of the pill and can be overcome by careful explanation of the pill\u2019s role as medical therapy. Objections may be based on concerns that hormonal therapy for medical indications is likely to hasten the onset of coitarche or sexual debut, although no data support this fear. If the medication"
        },
        {
            "id": "Gynecology_Novak_49",
            "title": "Gynecology_Novak",
            "content": "History After the chief complaint and characteristics of the present illness are ascertained, the medical history of the patient should be obtained. It should include her complete medical and surgical history, her reproductive history (including menstrual and obstetric history), her current use of medications (including over-the-counter and complementary and alternative medications), and a thorough family and social history."
        },
        {
            "id": "Pharmacology_Katzung_2257",
            "title": "Pharmacology_Katzung",
            "content": "Anthony J. Trevor, PhD not overweight, and she takes no prescription drugs. She drinks decaffeinated coffee but only one cup in the morning; however, she drinks as many as six cans per day of diet cola. She drinks a glass of wine with her evening meal but does not like stronger spirits. What other aspects of this patient\u2019s history would you like to know? What therapeutic measures are appropriate for this patient? What drug, or drugs, (if any) would you prescribe? At her annual physical examination, a 53-year-old middle school teacher complains that she has been having difficulty falling asleep, and after falling asleep, she awakens several times during the night. These episodes now occur almost nightly and are interfering with her ability to teach. She has tried various over-the-counter sleep remedies, but they were of little help and she experienced \u201changover\u201d effects on the day following their use. Her general health is good, she is"
        },
        {
            "id": "Gynecology_Novak_4465",
            "title": "Gynecology_Novak",
            "content": "History A thorough medical history should be obtained from every incontinent patient. The history should include a review of symptoms, general medical history, review of past surgery, and current medications. The woman\u2019s most troubling symptoms must be ascertained\u2014how often she leaks urine, how much urine she leaks, what provokes urine loss, what improves or worsens the problem, and what treatment (if any) she had in the past. It is essential to keep the patient\u2019s chief symptom at the forefront to avoid inappropriate management. Consider, for example, a woman whose chief concern is that once a month, while leading a business seminar, she has a sudden, overwhelming urge to void followed by complete bladder emptying. She finds this leakage devastating and is considering quitting her job because of her acute embarrassment. On occasion, she leaks a few drops of urine during exercise, but this minor leakage does not bother her. During the evaluation, urodynamics reveal minimal stress"
        },
        {
            "id": "Gynecology_Novak_2925",
            "title": "Gynecology_Novak",
            "content": "It is estimated that almost 40% to 50% of individuals with HIV are women. Intravenous drug use and heterosexual transmission are responsible for most of the cases of AIDS in women in the United States (52). Infection with HIV produces a spectrum of disease that progresses from an asymptomatic state to full-blown AIDS. The pace of disease progression in untreated adults is variable. The median time between infection with HIV and the development of AIDS is 10 years, with a range from a few months to more than 12 years. In a study of adults infected with HIV, symptoms developed in 70% to 85% of infected adults, and AIDS developed in 55% to 60% within 12 years after infection. The natural history of the disease can be significantly altered by antiretroviral therapy. Women with HIV-induced altered immune function are at increased risk for infections such as tuberculosis (TB), bacterial pneumonia, and Pneumocystis jiroveci pneumonia (PCP). Because of its impact on the immune system, HIV"
        },
        {
            "id": "Pharmacology_Katzung_3233",
            "title": "Pharmacology_Katzung",
            "content": "Charles DeBattista, MD house and has no motivation, interest, or energy to pursue recreational activities that she once enjoyed such as hiking. She describes herself as \u201cchronically miserable and worried all the time.\u201d Her medical history is notable for chronic neck pain from a motor vehicle accident for which she is being treated with tramadol and meperidine. In addition, she is on hydrochlorothiazide and propranolol for hypertension. The patient has a history of one depressive episode after a divorce that was treated successfully with fluoxetine. Medical workup including complete blood cell count, thyroid func-tion tests, and a chemistry panel reveals no abnormalities. She is started on fluoxetine for a presumed major depressive episode and referred for cognitive behavioral psychotherapy. What CYP450 and pharmacodynamic interactions might be associated with fluoxetine use in this patient? Which class of antidepressants would be contraindicated in this patient? A 47-year-old woman"
        },
        {
            "id": "InternalMed_Harrison_13587",
            "title": "InternalMed_Harrison",
            "content": "For active or suspected TB disease, clinical factors, including HIV co-infection, symptom duration, radiographic appearance, and public health concerns about TB transmission, drive diagnostic testing and treatment initiation. Multiple-drug regimens are used for the treatment of TB disease (Table 205e-2). Initially, an intensive phase consisting of four drugs\u2014isoniazid, rifampin, pyrazinamide, and ethambutol\u2014given for 2 months is followed by a continuation phase of isoniazid and rifampin for 4 months, for a total treatment duration of 6 months. The continuation phase is extended to 7 months (for a total treatment duration of 9 months) if the 2-month course of pyrazinamide is not completed or, for patients with cavitary pulmonary TB, if sputum cultures remain positive beyond 2 months of treatment (delayed culture conversion)."
        },
        {
            "id": "Gynecology_Novak_1984",
            "title": "Gynecology_Novak",
            "content": "she must understand that stopping the prescribed regimen may result in a recurrence of heavy bleeding. Both the patient and her mother should be warned to expect heavy withdrawal \ufb02ow for the first period. It will be controlled by the institution of combination low-dose oral contraceptive therapy, given once daily and continued for three to six cycles, to allow regular withdrawal \ufb02ow. If the patient is not sexually active, the pill may be discontinued after the recommended course of therapy and the menstrual cycles may be reassessed."
        },
        {
            "id": "Pharmacology_Katzung_5171",
            "title": "Pharmacology_Katzung",
            "content": "A 59-year-old woman presents to an urgent care clinic with a 4-day history of frequent and painful urination. She has had fevers, chills, and flank pain for the past 2 days. Her physician advised her to come immediately to the clinic for evaluation. In the clinic she is febrile (38.5\u00b0C [101.3\u00b0F]) but otherwise stable and states she is not experiencing any nausea or vomiting. Her urine dipstick test is positive for leukocyte esterase. Urinalysis and urine culture are ordered. Her past medical history is significant for three urinary tract infections in the past year. Each episode was uncom-plicated, treated with trimethoprim-sulfamethoxazole, and promptly resolved. She also has osteoporosis for which she takes a daily calcium supplement. The decision is made to treat her with oral antibiotics for a complicated urinary tract infection with close follow-up. Given her history, what would be a reasonable empiric antibiotic choice? Depending on the antibiotic choice are there potential drug"
        },
        {
            "id": "Biochemistry_Lippincott_175",
            "title": "Biochemistry_Lippinco",
            "content": "Choose the ONE best answer. .1. A 30-year-old woman of Northern European ancestry presents with progressive dyspnea (shortness of breath). She denies the use of cigarettes. Family history reveals that her sister also has problems with her lungs. Which one of the following etiologies most likely explains this patient\u2019s pulmonary symptoms? A. Deficiency in dietary vitamin C B. Deficiency of \u03b11-antitrypsin C. Deficiency of prolyl hydroxylase D. Decreased elastase activity E. Increased collagenase activity"
        },
        {
            "id": "Gynecology_Novak_2389",
            "title": "Gynecology_Novak",
            "content": "Tuberculosis should be excluded as a cause of pyelonephritis if the characteristic sterile pyuria is present and the patient\u2019s condition does not improve with antibiotics. All women of reproductive age with acute pelvic pain should have a complete blood count with differential, ESR, urinalysis, and a sensitive qualitative urine or serum pregnancy test. If not diagnosed expeditiously, an acute process can often result in significant morbidity or mortality. For patients who have chronic pelvic pain and develop acute exacerbation, it is important to rule out a superimposed acute process. Symptoms of fever, chills, diaphoresis, abnormal vaginal bleeding, dizziness, syncope, emesis, significant diarrhea, obstipation, dysuria, hematuria, and hematochezia, and/or signs of elevated temperature, tachycardia, orthostasis, abdominal distention, abnormal bowel sounds, ascites, peritonitis, or abnormal pregnancy are all indicative of an acute process."
        },
        {
            "id": "Pharmacology_Katzung_2439",
            "title": "Pharmacology_Katzung",
            "content": "Roger J. Porter, MD, & Michael A. Rogawski, MD, PhD was unchanged, and levetiracetam was gradually increased to 1000 mg bid. The patient had no significant adverse effects from this dosage. At age 21, she had a second tonic-clonic seizure while in college; further discussion with her room-mate at that time revealed a history of two recent episodes of 1\u20132 minutes of altered consciousness with lip smacking (focal impaired awareness seizure, formerly complex partial seizure). A repeat EEG showed occasional right temporal spikes. What is one possible strategy for controlling her present symptoms? A 23-year-old woman presents to the office for consultation regarding her antiseizure medications. Seven years ago, this otherwise healthy young woman had a tonic-clonic seizure at home. She was rushed to the emergency department, at which time she was alert but complained of headache. A consulting neurologist placed her on levetiracetam, 500 mg bid. Four days later, electroencephalography (EEG)"
        },
        {
            "id": "Pharmacology_Katzung_1897",
            "title": "Pharmacology_Katzung",
            "content": "The Eicosanoids: Prostaglandins, Thromboxanes, Leukotrienes, & Related Compounds John Hwa, MD, PhD, & Kathleen Martin, PhD* pulmonary pressures, and right ventricular enlargement. Cardiac catheterization confirmed the severely elevated pulmonary pressures. She was commenced on appropri-ate therapies. Which of the eicosanoid agonists have been demonstrated to reduce both morbidity and mortality in patients with such a diagnosis? What are the modes of action? A 40-year-old woman presented to her doctor with a 6-month history of increasing shortness of breath. This was associated with poor appetite and ankle swell-ing. On physical examination, she had elevated jugular venous distention, a soft tricuspid regurgitation murmur, clear lungs, and mild peripheral edema. An echocardio-gram revealed tricuspid regurgitation, severely elevated"
        },
        {
            "id": "Pharmacology_Katzung_2047",
            "title": "Pharmacology_Katzung",
            "content": "Joshua M. Galanter, MD, & Homer A. Boushey, MD and respirations are 32/min. Her mother states that she has used her albuterol inhaler several times a day for the past 3 days and twice during the previous night. She took an additional two puffs on her way to the emergency department, but her mother states that \u201cthe inhaler didn\u2019t seem to be helping so I told her not to take any more.\u201d What emergency measures are indicated? How should her long-term management be altered? A 14-year-old girl with a history of asthma requiring daily inhaled corticosteroid therapy and allergies to house dust mites, cats, grasses, and ragweed presents to the emergency department in mid-September, reporting a recent \u201ccold\u201d com-plicated by worsening shortness of breath and audible inspi-ratory and expiratory wheezing. She appears frightened and refuses to lie down but is not cyanotic. Her pulse is 120 bpm,"
        },
        {
            "id": "Pharmacology_Katzung_6478",
            "title": "Pharmacology_Katzung",
            "content": "Management of the Poisoned Patient Kent R. Olson, MD A 62-year-old woman with a history of depression is found in her apartment in a lethargic state. An empty bottle of bupro-pion is on the bedside table. In the emergency department, she is unresponsive to verbal and painful stimuli. She has a brief generalized seizure, followed by a respiratory arrest. The emergency physician performs endotracheal intubation and administers a drug intravenously, followed by another sub-stance via a nasogastric tube. The patient is admitted to the intensive care unit for continued supportive care and recovers the next morning. What drug might be used intravenously to prevent further seizures? What substance is commonly used to adsorb drugs still present in the gastrointestinal tract?"
        },
        {
            "id": "InternalMed_Harrison_13424",
            "title": "InternalMed_Harrison",
            "content": "Although the 6-month regimen described in Table 202-3 is generally effective for patients with initial isoniazid-resistant disease, it is prudent to include at least ethambutol and possibly pyrazinamide for the full 6 months and to consider extending the treatment course to 9 months. In such cases, isoniazid probably does not contribute to a successful outcome and could be omitted. In case of documented resistance to both isoniazid and ethambutol, a 9to 12-month regimen of rifampin, pyrazinamide, and a fluoroquinolone can be used. Any patients whose isolates exhibit resistance to rifampin should be managed as if they had MDR-TB (see below), with the addition of isoniazid if susceptibility to this agent is confirmed via rapid testing or is presumed. MDR-TB, in which bacilli are resistant to (at least) isoniazid and rifampin, is more difficult to manage than is disease caused by drug-susceptible organisms because these two bactericidal drugs are the most potent agents available and"
        },
        {
            "id": "Biochemistry_Lippincott_1244",
            "title": "Biochemistry_Lippinco",
            "content": "Choose the ONE best answer. For Questions 26.1 and 26.2, use the following scenario. A 40-year-old woman, 5 ft, 1 in (155 cm) tall and weighing 188 lb (85.5 kg), seeks your advice on how to lose weight. Her waist measured 41 in and her hips 39 in. The remainder of the physical examination and the blood laboratory data were all within the normal range. Her only child (who is age 14 years), her sister, and both of her parents are overweight. The patient recalls being overweight throughout her childhood and adolescence. Over the past 15 years, she had been on seven different diets for periods of 2 weeks to 3 months, losing from 5 to 25 lb each time. On discontinuation of the diets, she regained weight, returning to 185\u2013190 lb. 6.1. Calculate and interpret the body mass index for the patient. Body mass index (BMI) = weight in kg/(height in m)2 = 85.5/1.552 = 35.6. Because her BMI is >30, the patient is classified as obese."
        },
        {
            "id": "InternalMed_Harrison_13403",
            "title": "InternalMed_Harrison",
            "content": "of treatment can be given once-weekly rifapentine/isoniazid in the continuation phase. eThe 6-month regimen with pyrazinamide can probably be used safely during pregnancy and is recommended by the WHO and the International Union Against Tuberculosis and Lung Disease. If pyrazinamide is not included in the initial treatment regimen, the minimal duration of therapy is 9 months. fStreptomycin should be discontinued after 2 months. Drug susceptibility results will determine the best regimen option. gThe availability of rapid molecular methods to identify drug resistance allows initiation of a proper regimen at the start of treatment. hAlthough normally not recommended, a fluoroquinolone may strengthen the regimen for patients with extensive disease. A later-generation agent (such as levofloxacin, moxifloxacin, or possibly gatifloxacin; see text) is preferred. iIsoniazid is added if susceptibility to this agent is confirmed or presumed. jAmikacin and kanamycin (aminoglycosides) or"
        },
        {
            "id": "Pharmacology_Katzung_545",
            "title": "Pharmacology_Katzung",
            "content": "Introduction to Autonomic Pharmacology Bertram G. Katzung, MD, PhD A 56-year-old woman is brought to the university eye center with a complaint of \u201closs of vision.\u201d Because of visual impair-ment, she has lost her driver\u2019s license and has fallen several times in her home. Examination reveals that her eyelids close involuntarily with a frequency and duration sufficient to pre-vent her from seeing her surroundings for more than brief moments at a time. When she holds her eyelids open with her fingers, she can see normally. She has no other muscle dysfunction. A diagnosis of blepharospasm is made. Using a fine needle, several injections of botulinum toxin type A are made in the orbicularis oculi muscle of each eyelid. After observation in the waiting area, she is sent home. Two days later, she reports by telephone that her vision has improved dramatically. How did botulinum toxin improve her vision? How long can her vision be expected to remain normal after this single treatment?"
        },
        {
            "id": "Pharmacology_Katzung_7019",
            "title": "Pharmacology_Katzung",
            "content": "Her social history is significant for alcohol use (three to four glasses of wine/night). Her vital signs include the following: temperature 99.8\u00b0F, blood pressure 132/64 mm Hg, pulse 78 bpm, and respiratory rate 15/min. On physical examination, she had left upper abdominal tenderness with evidence of hepatomegaly and mild scleral icterus. Laboratory data revealed the following: alanine aminotransferase, 527 IU/L (normal 10\u201335 IU/L); aspartate aminotransferase, 425 IU/L (normal < 35 IU/L); and bilirubin, 2.9 mg/dL (normal 0.1\u20130.3 mg/dL). What medications do OTC cold and flu preparations typically contain? Which of the OTC medications might have contrib-uted to the patient\u2019s current symptoms? KH, a 55-year-old woman, presents to the emergency department with nausea, vomiting, and complaints of new-onset flu symptoms over the past several days. Her past medical history is significant for allergic rhinitis and chronic lower back pain secondary to a work-related fall 2 years ago. Her"
        },
        {
            "id": "InternalMed_Harrison_13406",
            "title": "InternalMed_Harrison",
            "content": "proper social support including education, psychosocial counseling, and material sustainment. In an increasing number of countries, personnel to supervise therapy are usually available through TB control programs of local public health departments and from members of the community who are accepted by the patient to undertake that role and who have been properly educated by health workers. Direct supervision with patient support usually increases the proportion of patients completing treatment in all settings and greatly lessens the chances of failure, relapse, and acquired drug resistance. Fixed-drug-combination products (e.g., isoniazid/rifampin, isoniazid/rifampin/pyrazinamide, and isoniazid/rifampin/pyrazinamide/ ethambutol) are available and are strongly recommended as a means of minimizing the likelihood of prescription error and of the development of drug resistance as the result of monotherapy. In some formulations of these combination products, the bioavailability of rifampin"
        },
        {
            "id": "InternalMed_Harrison_13397",
            "title": "InternalMed_Harrison",
            "content": "should always receive their initial-phase regimen daily (see below). A continuation phase of once-weekly rifapentine and isoniazid has been shown to be equally effective for HIV-seronegative patients with noncavitary pulmonary TB who have negative sputum cultures at 2 months. Patients with cavitary pulmonary TB and delayed sputum-culture conversion (i.e., those who remain culture-positive at 2 months) should be tested immediately for drug-resistant TB, and a change of regimen should be considered. To prevent isoniazid-related neuropathy, pyridoxine (10\u201325 mg/d) should be added to the regimen given to persons at high risk of vitamin B6 deficiency (e.g., alcoholics; malnourished persons; pregnant and lactating women; and patients with conditions such as chronic renal failure, diabetes, and HIV infection, which are also associated with neuropathy). A full course of therapy (completion of treatment) is defined more accurately by the total number of doses taken than by the duration of"
        },
        {
            "id": "Gynecology_Novak_822",
            "title": "Gynecology_Novak",
            "content": "A strong index of suspicion is required for diagnosis, especially in elderly and immunocompromised individuals, who have altered response mechanisms. This is true with \u201ctypical agents.\u201d Subtle clues in the elderly include changes in mentation, confusion, and exacerbation of other illnesses. The febrile response may be entirely absent, and the results of the physical examination are not predictive of pneumonia. In high-risk groups, an increased respiratory rate of greater than 25 breaths per minute remains the most reliable sign of infection. Mortality in these high-risk groups of patients is strongly correlated with the ability of the host to mount normal defenses to the symptoms of fever, chills, and tachycardia. All women suspected of having pneumonia should undergo chest radiography to establish the diagnosis and to detect alternate diagnoses such as congestive heart failure and tumors."
        },
        {
            "id": "Gynecology_Novak_1634",
            "title": "Gynecology_Novak",
            "content": "difficulties in the extremities can undertake an exercise regimen. The patient\u2019s preoccupation with her symptoms can be channeled into documentation of her progress in a log that she brings to her medical appointments. The physician is not bound to peruse the entire document at each visit. If it is too long, the patient can be asked to prepare a summary. This process may enlighten both her and the physician to the relationships between her symptoms and her diet, relationships, or activities. She should be advised not to dwell on her symptoms apart from this important notation (174)."
        },
        {
            "id": "Surgery_Schwartz_11843",
            "title": "Surgery_Schwartz",
            "content": "bowel involvement, etcBrunicardi_Ch41_p1783-p1826.indd 178818/02/19 4:34 PM 1789GYNECOLOGYCHAPTER 41or clotting issues and history, and drug exposure, allergies, and current medications must be addressed.Commonly Used Testinga-Human Chorionic Gonadotropin Testing. Qualitative uri-nary pregnancy tests for human chorionic gonadotropin (b-hCG) are standard prior to any surgery in a woman of reproductive age and potential, regardless of contraception history. In addition, serum quantitative b-hCG testing is appropriate for evaluation of suspected ectopic pregnancy, gestational trophoblastic dis-ease, or ovarian mass in a young woman. In the case of ectopic pregnancy, serial levels are required when a pregnancy cannot be identified in the uterine cavity by imaging. As a general rule, 85% of viable, very early intrauterine pregnancies will have at least a 66% rise in the b-hCG level over 48 hours.Table 41-2Features of common causes of vaginitis BACTERIAL VAGINOSISVULVOVAGINAL"
        },
        {
            "id": "InternalMed_Harrison_13442",
            "title": "InternalMed_Harrison",
            "content": "has recommended routine use of pyrazinamide for pregnant women, this drug has not been recommended in the United States because of insufficient data documenting its safety in pregnancy. Streptomycin is contraindicated because it is known to cause eighth-cranial-nerve damage in the fetus. Treatment for TB is not a contraindication to breast-feeding; most of the drugs administered will be present in small quantities in breast milk, albeit at concentrations far too low to provide any therapeutic or prophylactic benefit to the child. Medical consultation on difficult-to-manage cases is provided by the U.S. CDC Regional Training and Medical Consultation Centers (www.cdc.gov/tb/education/rtmc/)."
        },
        {
            "id": "Obstentrics_Williams_8988",
            "title": "Obstentrics_Williams",
            "content": "In some instances, a woman may present without symptoms but describes recent sexual contact with a person who has been diagnosed with syphilis. She should be evaluated clinically and serologically. If her partner is diagnosed and their sexual contact occurred within the preceding 90 days, the gravida is treated presumptively for early syphilis, even if serological test results are negative. his accounts for early infection but before seroconversion. If contact was earlier than 90 days ago, treatment is based on serological results (Workwoski, 2015). Women with a history of penicillin allergy should have either an oral stepwise penicillin-dose challenge or skin testing performed to confirm the risk of immunoglobulin E (IgE)mediated anaphylaxis. If conirmed, penicillin desensitization, shown in Table 65-2, is recommended and then followed by benzathine penicillin G treatment (Wendel, 1985). TABLE 65-2. Penicillin Allergy-Oral Desensitization"
        }
    ],
    "scores": [
        0.025047565702905505,
        0.023532818532818533,
        0.019704911667637354,
        0.018596642272922945,
        0.018018018018018018,
        0.017806267806267807,
        0.017648888197791944,
        0.01725925925925926,
        0.017242660720921593,
        0.01668520578420467,
        0.016611524676040806,
        0.01647058823529412,
        0.0160378517881283,
        0.01589323627540188,
        0.015866047911701993,
        0.015791945520723258,
        0.015445614865664575,
        0.015443098123069612,
        0.015363786202024958,
        0.015022265142979774,
        0.015020790020790022,
        0.014926189174412248,
        0.01482213438735178,
        0.014776524644945697,
        0.014535947712418302,
        0.014496314496314496,
        0.01436335403726708,
        0.014328951101863236,
        0.01418725159732354,
        0.014183708165347062,
        0.014088612514574427,
        0.013956193060670672
    ]
}